SARS-CoV RNA-dependent RNA polymerase

Target id: 3140

Nomenclature: SARS-CoV RNA-dependent RNA polymerase

References

Show »

1. Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M. (2020) Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. J Biol Chem, 295 (20): 6785-6797. [PMID:32284326]

How to cite this page

SARS-CoV RNA-dependent RNA polymerase. Last modified on 11/08/2020. Accessed on 23/05/2022. IUPHAR/BPS Guide to PHARMACOLOGY, http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3140.